Cargando…
Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus
BACKGROUND: The economic feasibility of pharmacotherapeutic empowerment of patients with type 2 diabetes mellitus (DM2) is still not well established. OBJECTIVES: To evaluate the cost-effectiveness of an individual pharmacotherapeutic empowerment strategy (IPES) for patients with DM2. METHODS: This...
Autores principales: | Gonçalves, Ana Carolina Oliveira, Cazarim, Maurílio de Souza, Sanches, Cristina, Pereira, Leonardo Regis Leira, Camargos, Ana Márcia Tomé, Aquino, Jéssica Azevedo, Oliveira Baldoni, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673768/ https://www.ncbi.nlm.nih.gov/pubmed/31413839 http://dx.doi.org/10.1136/bmjdrc-2018-000647 |
Ejemplares similares
-
Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil
por: Cazarim, Maurílio de Souza, et al.
Publicado: (2018) -
Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge
por: Cazarim, Maurílio de Souza, et al.
Publicado: (2016) -
Adherence to antidiabetic treatment and impaired hypoglycemia awareness in type 2 diabetes mellitus assessed in Spanish community pharmacies: the ADHIFAC study
por: Gomez-Peralta, Fernando, et al.
Publicado: (2021) -
Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judicially
por: Mendonça, Thays S., et al.
Publicado: (2022) -
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
por: Cazarim, Maurilio de Souza, et al.
Publicado: (2020)